RAI Strategic Holdings Inc. Files Patent Infringement Case

Business by 2FIRSTS.ai
Jun.13.2024
RAI Strategic Holdings Inc. Files Patent Infringement Case
RAI Strategic Holdings, Inc. files patent infringement complaint with USITC against 42 companies for certain e-cigarette products.

On June 11, 2024, RAI Strategic Holdings, Inc., R.J. Reynolds Tobacco Company, RAI Services Company, and R.J. Reynolds Vapor Company filed a complaint with the United States International Trade Commission under Section 337 of the Tariff Act of 1930, alleging patent infringement of certain e-cigarette products exported from the US, imported into the US, or sold in the US. They requested the initiation of a Section 337 investigation and the issuance of a general exclusion order, limited exclusion order, and cease and desist orders. A total of 42 companies from the US, China, the UK, and other countries are involved in the case.

 

According to documents from the U.S. International Trade Commission, the following companies have been listed as proposed defendants by Reynolds Tobacco because they are suspected of importing, selling, or distributing disposable electronic vaporization devices and their components that allegedly infringe U.S. Patent No. 11,925,202 ("the '202 patent").

 

The proposed respondents include the following companies:

 

1. Breeze Smoke, LLC 2. Capital Sales Company 3. KMT Services, LLC doing business as KMT Distribution and Dank Shop 4. Dongguan (Shenzhen) Shikai Technology Co., Ltd. 5. Vapeonly Technology Co. Ltd. 6. iMiracle (Shenzhen) Technology Co., Ltd. 7. Guangdong Qisitech Co., Ltd. 8. Fewo Intelligent Manufacturing, Ltd. 9. Nevera (HK) Ltd. 10. Guangdong Cellular Workshop Electronics Technology Co., Ltd. 11. Wonder Ladies Ltd. 12. Sailing South Ltd. 13. Marea Morada Ltd. 14. Social Brands, LLC 15. Zhuhai Qisitech Co., Ltd. 16. Shenzhen Han Technology Co., Ltd. 17. Palma Terra Ltd. 18. Shenzhen IVPS Technology Co., Ltd. 19. Heaven Gifts International Ltd. 20. Maduro Distributors Inc. doing business as The Loon 21. Bidi Vapor, LLC 22. Kaival Brands Innovations Group Inc. 23. Kimsun Technology (HuiZhou) Co., Ltd. 24. Shenzhen Yanyang Technology Co., Ltd. 25. Pastel Cartel, LLC 26. American Vape Company, LLC 27. Affiliated Imports, LLC 28. Shenzhen Innokin Technology Co., Ltd. 29. Shenzhen Funyin Electronic Technology Co., Ltd. 30. Shenzhen LC Technology Co., Ltd. 31. LCF Labs, Inc. 32. Shenzhen Kangvape Technology Co., Ltd. 33. Flumgio Technology Ltd. 34. Shenzhen Pingray Technology 35. SV3 LLC doing business as Mi-One Brands 36. Price Point Distributors Inc. doing business as Price Point NY 37. Flawless Vape Shop Inc. 38. Flawless Vape Wholesale & Distribution Inc. 39. Thesy, LLC doing business as Element Vape 40. VICA Trading Inc. doing business as Vapesourcing 41. Ecto World, LLC doing business as Demand Vape 42. Midwest Goods Inc. doing business as Midwest Distribution

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

DATA|UK Retail Research Group IGD Says Convenience Tobacco and Vape Sales Fell 10.6%, With 15.4% Market Share Versus Alcohol's 15.1%; Top Rank at Risk in 2027
DATA|UK Retail Research Group IGD Says Convenience Tobacco and Vape Sales Fell 10.6%, With 15.4% Market Share Versus Alcohol's 15.1%; Top Rank at Risk in 2027
Combined tobacco and vaping sales in UK convenience stores fell 10.6% year over year in the first half of 2026, making the category a major drag on channel performance, according to retail research organization IGD. Total convenience sales declined 1.2%, while sales excluding tobacco and vaping increased 0.7%. IGD's 2026 category-share figures show tobacco and vaping accounting for 15.4% of convenience sales, compared with 15.1% for alcohol. The organization forecasts alcohol could overtake tobacco and vaping as the largest category by sales value as early as 2027 if current trends continue. IGD expects the convenience market to increase from £48.6 billion in 2026 to £54.9 billion in 2031, a 2.5% compound annual growth rate, or 3.4% excluding tobacco and vaping.
DATA
Nov.11
Special report|Indonesia's Vape Industry Has 200 Manufacturers and $1.7 Billion in Investment. Could a Regulatory Divide Derail Its Rise as the World's No. 2 Manufacturing Hub After Shenzhen?
Special report|Indonesia's Vape Industry Has 200 Manufacturers and $1.7 Billion in Investment. Could a Regulatory Divide Derail Its Rise as the World's No. 2 Manufacturing Hub After Shenzhen?
Indonesia's Ministry of Industry said at a November 3, 2026, policy forum that the country has about 200 electronic cigarette companies, Rp31 trillion (approximately $1.71 billion) in cumulative industry investment and around 100,000 jobs across the supply chain. The National Narcotics Agency is seeking a comprehensive ban on vape use and circulation, while the industry ministry favors tighter import, product-standard and distribution controls. Indonesia exported approximately $518 million in vaping products in 2025, and Chinese manufacturers including Smoore, GEEKVAPE and Jinjia Group have established local operations. An international logistics specialist interviewed by 2Firsts said more Chinese vape companies began production in Indonesia from the second half of 2025, accompanied by increased shipments of manufacturing equipment and investment in logistics facilities. The regulatory debate comes as Indonesia expands its role in international vaping manufacturing.
Special Report
Nov.05
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives